• 목록
• 답변

Bio Venture Arbormed (CEO Kyojin Park, CEO Weonbin Im) announced on the 31st that they held the 'ESG Management Declaration Ceremony' at its headquarters in Seoul.

Arbormed adopts ESG as a basic management principle and plans to establish a new ESG management council for each sector with a CEO and operate regular communication channels to promote detailed mid- to long-term strategies.

ESG is a concept that encompasses the environment (E), society (S), and governance (G), which are non-financial factors that affect the sustainable growth of a company.
Corporate ESG management is becoming a global topic, and ESG is being reflected in the future management strategy decision-making process of many companies, especially large corporations, in Korea.
In particular, the importance is emerging for small and medium-sized enterprises (SMEs) and venture companies, where it was difficult to introduce ESG management due to business conditions in the past.

Arbormed has selected ‘pursuit of environment-friendly new drug development’, ‘consideration for the socially underprivileged’, and ‘compliance with laws and ethics and transparent management activities’
as the basic principles of ESG management. To this end, it was decided to establish and operate detailed promotion strategies for each sector.

Kyojin Park, CEO of Arbormed, said, “Starting with this declaration, we will actively promote ESG management so that it can become a stepping stone for a company that pursues eco-friendly, social responsibility,
and sound public governance rather than just a management strategy.” We will become a leading company in sustainable management through more diversified and advanced strategy establishment and systematic management.”

Meanwhile, in addition to developing treatments for rare hereditary diseases such as Wilson's disease and congenital deafness and incurable diseases such as acute respiratory distress syndrome,
Arbormed is conducting FDA approval of Complex Generic and distribution business in the US. In particular, in relation to Wilson's disease, achievements have been announced at the European Association for the Study of the Liver, the American Association for the Study of the Liver, etc., and research papers published in authoritative journals have been published one after another, drawing attention from the related academic and industry sectors.